ResMed Inc (RMD.AX)

Name: ResMed Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Instruments Supplies

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$1.4B

Net Income

$393M

Operating Margin

35.0%

Free Cash Flow

$1.7B

Debt / Assets

27.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for ResMed Inc (RMD.AX).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-03-31	2024-12-31
Revenue	1,422,808,000	1,335,582,000	1,291,736,000	1,282,089,000
Cost of Revenue	538,148,000	514,762,000	525,328,000	530,814,000
Gross Profit	884,660,000	820,820,000	766,408,000	751,275,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	278,396,000	259,194,000	245,302,000	241,613,000
Operating Expenses	387,065,000	374,283,000	340,139,000	334,033,000
Operating Income	497,595,000	446,537,000	426,268,000	417,242,000
Interest Expense	7,949,000	8,793,000	0	-2,436,000
Income Before Tax	496,147,000	446,793,000	417,693,000	418,323,000
Income Tax Expense	103,554,000	98,257,000	52,652,000	73,701,000
Net Income	392,593,000	348,536,000	365,041,000	344,622,000
Per Share
EPS	2.69	2.38	2.49	2.43
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for ResMed Inc (RMD.AX).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Revenue	5,146,327,000	4,685,297,000	4,222,993,000	3,196,825,000
Cost of Revenue	2,091,357,000	2,029,994,000	1,867,331,000	1,357,725,000
Gross Profit	3,054,970,000	2,655,303,000	2,355,662,000	1,839,100,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	991,019,000	917,136,000	874,003,000	670,387,000
Operating Expenses	1,369,607,000	1,335,410,000	1,203,665,000	926,749,000
Operating Income	1,685,363,000	1,319,893,000	1,131,871,000	903,678,000
Interest Expense	12,609,000	45,708,000	47,379,000	23,989,000
Income Before Tax	1,677,566,000	1,264,798,000	1,101,664,000	883,662,000
Income Tax Expense	276,843,000	243,847,000	204,108,000	409,157,000
Net Income	1,400,723,000	1,020,951,000	897,556,000	474,505,000
Per Share
EPS	9.55	6.94	6.12	0.32
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for ResMed Inc (RMD.AX).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	1,209,450,000	238,361,000	227,891,000	295,278,000
Short Term Investments	0	0	12,423,000	9,167,000
Net Receivables	990,667,000	837,275,000	704,909,000	614,292,000
Inventory	927,711,000	822,250,000	998,012,000	457,033,000
Total Current Assets	3,505,605,000	2,357,719,000	2,367,830,000	1,574,757,000
Property Plant Equipment	718,287,000	699,146,000	665,811,000	592,065,000
Goodwill and Intangibles	3,511,541,000	3,327,959,000	3,322,640,000	2,320,483,000
Total Assets	8,174,391,000	6,872,394,000	6,751,708,000	4,728,125,000
Liabilities
Account Payables	278,157,000	237,728,000	150,756,000	138,008,000
Short Term Debt	40,406,000	35,178,000	31,821,000	35,585,000
Total Current Liabilities	1,019,120,000	910,655,000	758,533,000	911,766,000
Long Term Debt	811,407,000	838,757,000	1,548,087,000	758,130,000
Total Liabilities	2,206,532,000	2,008,351,000	2,621,805,000	1,842,446,000
Shareholders Equity
Retained Earnings	6,081,490,000	4,991,647,000	4,253,016,000	3,079,640,000
Total Shareholders Equity	5,967,859,000	4,864,043,000	4,129,903,000	2,885,679,000

Balance sheet annual history for ResMed Inc (RMD.AX).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	1,209,450,000	238,361,000	227,891,000	295,278,000
Short Term Investments	0	0	12,423,000	9,167,000
Net Receivables	990,667,000	837,275,000	704,909,000	614,292,000
Inventory	927,711,000	822,250,000	998,012,000	457,033,000
Total Current Assets	3,505,605,000	2,357,719,000	2,367,830,000	1,574,757,000
Property Plant Equipment	718,287,000	699,146,000	665,811,000	592,065,000
Goodwill and Intangibles	3,511,541,000	3,327,959,000	3,322,640,000	2,320,483,000
Total Assets	8,174,391,000	6,872,394,000	6,751,708,000	4,728,125,000
Liabilities
Account Payables	278,157,000	237,728,000	150,756,000	138,008,000
Short Term Debt	40,406,000	35,178,000	31,821,000	35,585,000
Total Current Liabilities	1,019,120,000	910,655,000	758,533,000	911,766,000
Long Term Debt	811,407,000	838,757,000	1,548,087,000	758,130,000
Total Liabilities	2,206,532,000	2,008,351,000	2,621,805,000	1,842,446,000
Shareholders Equity
Retained Earnings	6,081,490,000	4,991,647,000	4,253,016,000	3,079,640,000
Total Shareholders Equity	5,967,859,000	4,864,043,000	4,129,903,000	2,885,679,000

Cash flow quarterly history for ResMed Inc (RMD.AX).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	1,400,723,000	1,020,951,000	897,556,000	474,505,000
Depreciation & Amortization	235,811,000	216,209,000	197,562,000	191,518,000
Stock Based Compensation	91,661,000	80,184,000	71,142,000	63,927,000
Change in Working Capital	16,738,000	44,784,000	-462,127,000	1,405,000
Operating Cash Flow	1,751,588,000	1,401,260,000	693,299,000	736,718,000
Investing Activities
Capital Expenditure	-89,865,000	-114,856,000	-134,000,000	-116,826,000
Investments	-89,865,000	-99,460,000	-134,000,000	-116,826,000
Investing Cash Flow	-200,045,000	-269,784,000	-1,159,845,000	-158,462,000
Financing Activities
Debt Repayment	-40,000,000	-730,000,000	-665,000,000	-612,000,000
Common Stock Issued/Repurchased	-225,586,000	-96,917,000	18,511,000	127,790,000
Dividends Paid	-310,880,000	-282,320,000	-258,276,000	-226,713,000
Financing Cash Flow	-606,253,000	-1,119,287,000	422,874,000	-764,632,000
Summary
Free Cash Flow	1,661,723,000	1,286,404,000	559,299,000	619,892,000
Net Change in Cash	971,089,000	10,470,000	-45,819,000	-167,878,000

Cash flow annual history for ResMed Inc (RMD.AX).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	1,400,723,000	1,020,951,000	897,556,000	474,505,000
Depreciation & Amortization	235,811,000	216,209,000	197,562,000	191,518,000
Stock Based Compensation	91,661,000	80,184,000	71,142,000	63,927,000
Change in Working Capital	16,738,000	44,784,000	-462,127,000	1,405,000
Operating Cash Flow	1,751,588,000	1,401,260,000	693,299,000	736,718,000
Investing Activities
Capital Expenditure	-89,865,000	-114,856,000	-134,000,000	-116,826,000
Investments	-89,865,000	-99,460,000	-134,000,000	-116,826,000
Investing Cash Flow	-200,045,000	-269,784,000	-1,159,845,000	-158,462,000
Financing Activities
Debt Repayment	-40,000,000	-730,000,000	-665,000,000	-612,000,000
Common Stock Issued/Repurchased	-225,586,000	-96,917,000	18,511,000	127,790,000
Dividends Paid	-310,880,000	-282,320,000	-258,276,000	-226,713,000
Financing Cash Flow	-606,253,000	-1,119,287,000	422,874,000	-764,632,000
Summary
Free Cash Flow	1,661,723,000	1,286,404,000	559,299,000	619,892,000
Net Change in Cash	971,089,000	10,470,000	-45,819,000	-167,878,000